Goldman Sachs turns bearish on Barbie maker
Wall Street has spent most of 2026 losing patience with Mattel (MAT), and Goldman Sachs just made that clear. The…
The Archive
Every market briefing, in one place.
In-depth analysis on the Fed, earnings, labor, commodities, and the news that moves markets. Filter by topic to find what you’re looking for.
Prediction: SpaceX Shares Can Reach $220 by End of 2026
Key Points SpaceX’s post-IPO pullback has shifted investor focus toward the company’s next phase of growth. Starlink, AI compute contracts,…
J.P. Morgan Called a Potential Elon Musk SpaceX-Tesla Merger “Strategically Coherent”
Key Points Now that Elon Musk’s rocket and satellite company Space Exploration Technologies (NASDAQ: SPCX) trades publicly, Wall Street has…
What This Immunome Sale Means a Day Before a Big FDA Milestone
Key Points An Immunome insider sold 100,000 shares for $2.4 million based on weighted average prices on July 6, 2026…
Retiring with $1.2 Million? Here’s How to Avoid Running Out of Savings
Key Points As always, The Motley Fool cannot and does not provide personalized investing or financial advice. This information is…
Kymera’s CEO Sold $6 Million in Stock After a 170% Run
Key Points According to a Form 4, proceeds of approximately $6.0 million were realized from the exercise and immediate sale…
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
Vertex Pharmaceuticals (NASDAQ:VRTX) said it has entered into a definitive agreement to acquire Crinetics Pharmaceuticals for $85 per share in…
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?
Key Points Comparing First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) and iShares Biotechnology ETF (NASDAQ:IBB) reveals a choice between…
Hogs Posting Mixed Trade on Friday
Lean hog futures are mixed at midday with contracts up 52 cents higher to 65 cents lower. USDA’s national base hog…